Features

We need your help to secure the $200 million KidneyX Artificial Kidney Prize to address challenges facing people with kidney diseases during the pandemic.

As a chef and instructor at a culinary school Duane Sunwold knows a lot about food. But when he received a diagnosis of chronic kidney disease (CKD) in 2000, he discovered he still had a lot to learn.

To mitigate the risk of COVID-19 infection, a recent white paper released by the Kidney Health Initiative (KHI) Board of Directors urges KHI stakeholders to accelerate the development of home-based technologies for people with kidney failure (1).

Among patients with hypertension, previous treatment with angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARBs) does not increase the risk of severe or fatal COVID-19, concludes a study in The Journal of the American Medical Association.

Urate-lowering therapy does not reduce the risk of progression in patients with chronic kidney disease (CKD), reports The New England Journal of Medicine./kidneynews/12_8/23/graphic/23f1.jpg

Pages